Howard Safir
CIK 1221559 · CEO, SC&I unit · last filed 2022-10-06
Howard Safir is a CEO, SC&I unit who has filed 49 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for CTXR, was dated Oct 6, 2022. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history. 11 SEC filings were submitted jointly with Citius Pharmaceuticals, Inc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
VRNT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
FIRST FLOOR
CRANFORD, NJ 07016
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CTXR | Director | — | $0.45 | — | $0 | 1 | 2022-10-06 |
| Citius Pharmaceuticals, Inc. (CTXRW) Delisted | Director | — | $0.14 | — | $0 | 8 | 2021-10-13 |
| VERINT SYSTEMS INC (VRNT) Delisted | Director | 30,838 | $20.51 | $632.5K | -$1.39M | 31 | 2021-04-22 |
| WALKER INNOVATION INC. (GLOI) Delisted | CEO, SC&I unit | 298,443 | — | — | $0 | 2 | 2008-06-30 |
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-10-06 | CTXR | Grant (A) | — | $0 | EDGAR |
| 2021-10-13 | Citius Pharmaceuticals, Inc. (CTXRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-26 | Citius Pharmaceuticals, Inc. (CTXRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-22 | VERINT SYSTEMS INC (VRNT) Delisted | Grant (A) | +4,178 | $0 | EDGAR |
| 2021-02-18 | Citius Pharmaceuticals, Inc. (CTXRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-16 | VERINT SYSTEMS INC (VRNT) Delisted | Sell (S) | −8,333 | -$501.7K | EDGAR |
| 2020-10-09 | Citius Pharmaceuticals, Inc. (CTXRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-08-28 | VERINT SYSTEMS INC (VRNT) Delisted | Grant (A) | +4,326 | $0 | EDGAR |
| 2020-07-09 | Citius Pharmaceuticals, Inc. (CTXRW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-10-10 | Citius Pharmaceuticals, Inc. (CTXRW) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.